Fresh scientific discussion has emerged around a possible association between paracetamol use and autism spectrum disorder, reigniting a sensitive and closely watched public health debate. Recent studies have prompted researchers to re-examine long-standing assumptions about the medication’s safety profile, particularly when used during pregnancy or early childhood. While experts caution that no definitive causal link has been established, the renewed focus underscores the complexity of neurodevelopmental research and the need for rigorous, long-term data.
